# Edgemode, Inc.: overview EDGM · OTC · CIK 1652958 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/edgm.md) · [Financials](/companies/edgm/financials.md) · [Filings](/companies/edgm/filings.md) · [Insiders](/companies/edgm/insiders.md) Latest reported revenue: [$0](/filings/0001683168-26-006473.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001683168-26-006473). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001683168-26-004353.md) | [0.0 d](/filings/0001683168-26-006473.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.00](/filings/0001683168-25-008441.md) | not reported | [(0.05)](/filings/0001683168-26-004353.md) | [0.00](/filings/0001683168-26-006473.md) | [0.00](/filings/0001683168-25-008441.md) | not reported | [0.00](/filings/0001683168-26-004353.md) | [0.00](/filings/0001683168-26-006473.md) | | Free cash flow | $k | [24.8 d](/filings/0001683168-25-008441.md) | [(5.1) d](/filings/0001683168-26-002865.md) | not reported | not reported | [(309) d](/filings/0001683168-25-008441.md) | [(473) d](/filings/0001683168-26-002865.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 6-month figure less the 3-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 6-month figure less the 3-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,573](/filings/0001683168-23-002430.md) | [438](/filings/0001683168-25-001176.md) | [0.0](/filings/0001683168-25-003051.md) | [0.0](/filings/0001683168-26-002865.md) | [0.0](/filings/0001683168-26-002865.md) | | Gross margin | % | [14.3%](/filings/0001683168-23-002430.md) | [(85.6%)](/filings/0001683168-25-001176.md) | not reported | not reported | not reported | | Operating margin | % | [(210.2%)](/filings/0001683168-23-002430.md) | [(7165.9%)](/filings/0001683168-25-001176.md) | not reported | not reported | not reported | | Net margin | % | [(226.3%)](/filings/0001683168-23-002430.md) | [(7361.4%)](/filings/0001683168-25-001176.md) | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.02)](/filings/0001683168-23-002430.md) | [(0.09)](/filings/0001683168-25-001176.md) | [(0.01)](/filings/0001683168-25-003051.md) | [0.00](/filings/0001683168-26-002865.md) | [(0.01)](/filings/0001683168-26-002865.md) | | Free cash flow | $k | not reported | not reported | not reported | [17.7](/filings/0001683168-26-002865.md) | [(874)](/filings/0001683168-26-002865.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/edgm/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Hodges Capital Management Inc.](/funds/1337263.md) | 2026-06-30 | $114 | 30,000 | | Unchanged | ## Recent filings [All 235 filings](/companies/edgm/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 16:05 ET | [8-K](/filings/0001683168-26-008045.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-26-008045 | | 2026-10-16 | 20:03 ET | [8-K](/filings/0001683168-26-007930.md) | 8.01 Other events | 0001683168-26-007930 | | 2026-08-21 | 21:09 ET | [8-K](/filings/0001683168-26-006657.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-26-006657 | | 2026-08-14 | 20:06 ET | [10-Q](/filings/0001683168-26-006473.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006473 | | 2026-07-15 | 20:05 ET | [8-K](/filings/0001683168-26-005551.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-005551 | | 2026-07-14 | 20:05 ET | [8-K](/filings/0001683168-26-005525.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-26-005525 | | 2026-07-06 | 20:05 ET | [8-K](/filings/0001683168-26-005308.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-005308 | | 2026-07-01 | 21:06 ET | [SCHEDULE 13D/A](/filings/0001493152-26-031580.md) | Ownership report, active investor, amended | 0001493152-26-031580 | | 2026-06-29 | 11:59 ET | [8-K](/filings/0001683168-26-005143.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-005143 | | 2026-06-09 | 20:03 ET | [8-K](/filings/0001683168-26-004655.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-26-004655 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001683168-26-002865.md), filed Apr 13, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/38d89e6c-8c2c-41f4-8c40-41918dbfdcbf) ## About the filer - CIK: 1652958 - Tickers: EDGM - Exchange: OTC - SIC code: 8082 Services-Home Health Care Services - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.